Search research articles
Contact Us
Filters
Showing results (211-220 of 284) with videos related to
Page
of 29
Sort By:
British Journal of Pharmacology
|
June 29, 1999
Nitric oxide synthase inhibition by dimaprit and dimaprit analogues
J B Paquay, P A Hoen, H P Voss, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds
J E van Muijlwijk-Koezen, H Timmerman, R Link, et al.
European Journal of Pharmacology
|
June 19, 1987
HA autoreceptor assay with superfused slices of rat brain cortex and electrical stimulation
J F Van der Werf, A Bast, G J Bijloo, et al.
European Journal of Pharmacology
|
July 21, 1994
Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice
H Yokoyama, K Onodera, K Maeyama, et al.
Brain Research
|
December 16, 1996
Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit binding
T Mochizuki, F P Jansen, R Leurs, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives
J E van Muijlwijk-Koezen, H Timmerman, R Link, et al.
Regulatory Toxicology and Pharmacology : RTP
|
June 1, 1995
Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds
E J De Waal, H H Timmerman, P M Dortant, et al.
The Journal of Biological Chemistry
|
March 29, 1996
Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 --> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists
M J Smit, E Roovers, H Timmerman, et al.
Bioorganic & Medicinal Chemistry
|
October 26, 1999
Evaluation of [18F]VUF 5000 as a potential PET ligand for brain imaging of the histamine H3 receptor
A D Windhorst, H Timmerman, R P Klok, et al.
Journal of Molecular Graphics
|
December 1, 1994
A new model for the agonistic binding site on the histamine H2-receptor: the catalytic triad in serine proteases as a model for the binding site of histamine H2-receptor agonists
P H Nederkoorn, P Vernooijs, G M Donné-Op den Kelder, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 284) with videos related to
Sort By:
Page
of 29
British Journal of Pharmacology
|
June 29, 1999
Nitric oxide synthase inhibition by dimaprit and dimaprit analogues
J B Paquay, P A Hoen, H P Voss, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds
J E van Muijlwijk-Koezen, H Timmerman, R Link, et al.
European Journal of Pharmacology
|
June 19, 1987
HA autoreceptor assay with superfused slices of rat brain cortex and electrical stimulation
J F Van der Werf, A Bast, G J Bijloo, et al.
European Journal of Pharmacology
|
July 21, 1994
Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice
H Yokoyama, K Onodera, K Maeyama, et al.
Brain Research
|
December 16, 1996
Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit binding
T Mochizuki, F P Jansen, R Leurs, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives
J E van Muijlwijk-Koezen, H Timmerman, R Link, et al.
Regulatory Toxicology and Pharmacology : RTP
|
June 1, 1995
Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds
E J De Waal, H H Timmerman, P M Dortant, et al.
The Journal of Biological Chemistry
|
March 29, 1996
Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 --> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists
M J Smit, E Roovers, H Timmerman, et al.
Bioorganic & Medicinal Chemistry
|
October 26, 1999
Evaluation of [18F]VUF 5000 as a potential PET ligand for brain imaging of the histamine H3 receptor
A D Windhorst, H Timmerman, R P Klok, et al.
Journal of Molecular Graphics
|
December 1, 1994
A new model for the agonistic binding site on the histamine H2-receptor: the catalytic triad in serine proteases as a model for the binding site of histamine H2-receptor agonists
P H Nederkoorn, P Vernooijs, G M Donné-Op den Kelder, et al.
Page
of 29